As a seasoned Congenital Heart Surgeon, Tim combines surgical precision with startup acumen, making him an invaluable asset in the realm of healthcare ventures.

Alex is an entrepreneur, investor and healthcare operational strategist with 16+ years of experience. Initially a trauma and neurosurgery PA, Alex pivoted to leadership roles and is currently the VP of Clinical Strategy & Innovation for CareAbout Health where he leverages technology to drive value-based care for multispecialty practices. He is also the founder of MedTriArch Group, where his team provides strategic and operational support to start-ups across the healthcare ecosystem.

Joe is a seasoned C-Suite Healthcare Executive with a strong background in value-based care and integrated delivery systems, most recently serving as COO of Cleerly Health. Previously, he held key roles such as CMO at Elara Caring and Signify Health, CEO of Dignity Health Medical Foundation, and President of Humana’s $3.3B Care Delivery Organization. Joe brings decades of experience implementing clinical strategy and care delivery for providers, payors, and patients.

Elizabeth is a healthcare strategist specializing in diagnostics, digital health, and clinical systems, with a focus on evaluating and translating technical innovations into scalable clinical and commercial realities. Over 17 years at Roche, she led cross-functional initiatives spanning FDA-cleared and CE-IVD platforms, oncology decision support, population analytics, and early-stage healthcare strategy, bringing scientific rigor and operational perspective to investment evaluation.

Jeff Bass is Managing Member of Executive Strategies Group LLC, specializing in strategic planning, M&A, and business succession. He is Founding Chairman Emeritus of the Long Island Capital Alliance, connecting regional businesses with capital. He previously served as Principal-in-Charge of Business Advisory Services at Margolin, Winer & Evens, and as an Associate Trustee of what is now Northwell Health and founding board member of the Feinstein Medical Research Institutes.

Aram is the founder of The VC Factory and an advisor focused on decision-making under uncertainty in venture capital, entrepreneurship, and investment strategy. With a background spanning private equity, LBOs, growth equity, and venture investing, he works with LPs, GPs, and founders to improve fundraising, mindset-based investing, and leadership frameworks that bridge psychology with practical capital allocation.

Gus seasoned entrepreneur, technologist, and investor, serving as Founder & CEO of Xogito Group, a product development and management consulting firm that helps startups and enterprises with business transformation, AI-powered solutions, and scaling ambitious technology initiatives. With over 20 years as an internet pioneer, he has built award-winning platforms for major companies and founded or advised numerous ventures across technology and emerging sectors.

Neeraj is a seasoned entrepreneur with over 25 years of experience in software development, digital transformation, and building scalable technology systems. He has successfully launched and scaled multiple startups, bringing deep expertise in enterprise systems, messaging infrastructure, and AI-native workflows.

Rishie a general internist, Deputy Chief of Medicine, and Director of Medical Education at Unity Health Toronto, where he combines clinical practice with leadership in medical education and healthcare administration. He also serves as Assistant Professor at the University of Toronto and previously acted as a medical advisor for VentureSouq in the UAE, bringing a unique international and operational perspective to healthcare innovation.

Sophie Persaud, MSE, is an NIH-funded MD-PhD candidate in biomedical engineering focused on digital health. She builds, validates, and translates computational models and AI-enabled technologies for clinical use, with an emphasis on technical rigor, clinical validity, and translational execution. She serves as Director of Research at Nucleate Chicago, where she scouts and evaluates early-stage biotechnology.